ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) is -76.02% lower on its value in year-to-date trading and has touched a low of $0.32 and a high of $2.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IPA stock was last observed hovering at around $0.40 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.41, the stock is 1.71% and -8.96% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.12 million and changing 1.50% at the moment leaves the stock -53.39% off its SMA200. IPA registered -69.63% loss for a year compared to 6-month loss of -59.20%. The firm has a 50-day simple moving average (SMA 50) of $0.44822 and a 200-day simple moving average (SMA200) of $0.87559.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.04% gain in the last 1 month and extending the period to 3 months gives it a -39.71%, and is -4.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.35% over the week and 10.40% over the month.
ImmunoPrecise Antibodies Ltd (IPA) has around 101 employees, a market worth around $12.77M and $17.69M in sales. Profit margin for the company is -114.53%. Distance from 52-week low is 24.69% and -84.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.68%).
The EPS is expected to grow by 63.16% this year.
ImmunoPrecise Antibodies Ltd (IPA) Top Institutional Holders
20.0 institutions hold shares in ImmunoPrecise Antibodies Ltd (IPA), with institutional investors hold 7.48% of the company’s shares. The shares outstanding are 30.29M, and float is at 21.81M with Short Float at 0.69%. Institutions hold 6.58% of the Float.
The top institutional shareholder in the company is INGALLS & SNYDER LLC with over 1.3 million shares valued at $1.31 million. The investor’s holdings represent 5.0209% of the IPA Shares outstanding. As of 2024-06-30, the second largest holder is RENAISSANCE TECHNOLOGIES LLC with 63910.0 shares valued at $64549.0 to account for 0.2477 of the shares outstanding. The other top investors are BANK OF MONTREAL /CAN/ which holds 55857.0 shares representing 0.2165% and valued at over $61443.0, while NORTHERN TRUST CORP holds 0.1966 of the shares totaling 50730.0 with a market value of $51238.0.
ImmunoPrecise Antibodies Ltd (IPA) Insider Activity
#####
